Axogen
Manufacturing · Florida, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
13631 Progress Blvd Ste 400, Alachua, Fl...Phone Number
(386) 462-6800Website
www.axogeninc.comRevenue
$251.2 MillionStock Symbol
AXGNIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Axogen
Axogen is a biotechnology and medical technology company dedicated to the development, commercialization, and advancement of innovative solutions for peripheral nerve repair and regeneration. The company focuses on addressing the challenges associated with nerve injuries by providing specialized products and technologies designed to support the restoration of nerve function and improve patient outcomes.Explore more
Axogen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Axogen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Axogen is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Axogen had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Axogen
Earning: See what the market has to say on Axogen recently announced quarterly report
Check if Axogen has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Axogen launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Axogen has new funding data
Axogen, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Axogen
Find 3 more new buyers
Compare Similar Companies to Axogen
Compare insights from companies similar to Axogen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Axogen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Axogen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Axogen.
Axogen financials insights
Gather financial insights about Axogen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2006
Series B
$7.8M
2007
Series C
$12.1M
2009
Debt
$2.6M
2011
Debt
$3.7M
Debt
$3M
2013
Stock Offering
$18M
2015
Share Placement
$17.1M
2020
Debt
$35M
Axogen Tech Stack
A closer look at the technologies used by Axogen
Most Recent Scoops
Earnings
noted that the impact of commercial payer coverage wins on procedure growth typically requires a minimum of six months to fully materialize, as approvals must be socialized with physicians and institutions and payment rates negotiated, and that same-store sales growth from existing believers remains the primary driver of current revenue growth, with new program starts expected to contribute more meaningfully in H2 2026 and into 2027.
Sales, Revenue Operations
Earnings
AxoGen has updated its full year 2026 guidance to expect revenue growth of at least 24%, or revenue of at least $279 million, with gross margin of at least 73%, and continues to expect to be free cash flow positive for the full year 2026.
Earnings, Forecasting, Finance
Earnings
reported research and development expenses of $8.6 million for Q2 2026, an increase of 25.3% compared to $6.9 million in Q2 2025, representing 12.3% of total revenue compared to 12.1% in Q2 2025.
Earnings, Research & Development, Finance
Earnings
reported that its breast market grew 47% year over year through H1 2026, with approximately 215 active breast programs, an increase of over 40 programs year over year, and approximately 560 active surgeons, an increase of over 150 surgeons year over year.
Sales, Forecasting
Earnings
CRM, Earnings, Account Management, Finance
Axogen News & Media
Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026
ALACHUA, Fla. and TAMPA, Fla., July 15, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it will release financial results for the second quarter of 2026 on Wednesday, July 29, 2026. Axogen management will host an investment-community conference call and webcast at 8:00 a.m. ET following the release.Axogen, Inc. (AXGN) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
Axogen, Inc. (AXGN) Bank of America Global Healthcare Conference 2026 May 13, 2026 12:35 PM EDTCompany ParticipantsMichael Dale - President, CEO &...Axogen CMO sells 4,000 shares in open market | AXGN Insider Trading - Stock Titan
Axogen CMO Jens Kemp sold 4,000 AXGN shares at a weighted $43.44, in multiple trades between $43.44 and $43.45, leaving him with 72,451 shares.Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference
ALACHUA, Fla. and TAMPA, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that the company will be participating in the upcoming 2026 Bank of America Global Healthcare Conference.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Axogen
Sign Up For FreeTo access detailed company insights
Axogen is a biotechnology and medical technology company dedicated to the development, commercialization, and advancement of innovative solutions for peripheral nerve repair and regeneration. The company focuses on addressing the challenges associated with nerve injuries by providing specialized products and technologies designed to support the res... Read More
